June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Japan Eye Genetics Consortium: National Cohort Survey and Whole Exome Sequencing Results of Cone-rod dystrophy
Author Affiliations & Notes
  • Kaoru Fujinami
    Genetics, UCL Institute of Ophthalmology, University College London, London, UK, London, England, United Kingdom
  • Kazutoshi Yoshitake
    Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Tokyo, Japan
  • Takaaki Hayashi
    Ophthalmology, The Jikei University School of Medicine, Tokyo, Tokyo, Japan
  • Shinji Ueno
    Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
  • Atsushi Mizota
    Ophthalmology, Teikyo University School of Medicine, Tokyo, Tokyo, Japan
  • Kei Shinoda
    Ophthalmology, Saitama Medical University, Iruma District, Saitama, Japan
  • Kazuki Kuniyoshi
    Ophthalmology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan
  • Mineo Kondo
    Ophthalmology, Mie University Graduate School of Medicine, Tsu, Mie, Japan
  • Shuhei Kameya
    Ophthalmology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan
  • Kiyofumi Mochizuki
    Ophthalmology, Gifu University Graduate School of Medicine, Gifu, Gifu, Japan
  • Yozo Miyake
    Aichi Medical University, Nagakute, Aichi, Japan
  • Takeshi Iwata
    Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Tokyo, Japan
  • Kazushige Tsunoda
    Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Kaoru Fujinami, Acucela Inc. (C), Acucela Inc. (R), Astellas Pharma Inc (C), Astellas Pharma Inc (R), Astellas Pharma Inc (F), Foundation Fighting Blindness (R), Foundation Fighting Blindness Clinical Research Institute (R), Janssen Pharmaceutical K.K. (S), Japanese Ophthalmology Society (R), Japan Retinitis Pigmentosa Society (R), Kubota Pharmaceutical Holdings Co., Ltd (C), MeiraGTx LTD (S), NightstaRx (R), Novartis Pharma K.K. (C), Sanofi Genzyme (S), SANTEN Company Limited (R); Kazutoshi Yoshitake, None; Takaaki Hayashi, None; Shinji Ueno, None; Atsushi Mizota, None; Kei Shinoda, None; Kazuki Kuniyoshi, None; Mineo Kondo, None; Shuhei Kameya, None; Kiyofumi Mochizuki, None; Yozo Miyake, None; Takeshi Iwata, None; Kazushige Tsunoda, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 2382. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kaoru Fujinami, Kazutoshi Yoshitake, Takaaki Hayashi, Shinji Ueno, Atsushi Mizota, Kei Shinoda, Kazuki Kuniyoshi, Mineo Kondo, Shuhei Kameya, Kiyofumi Mochizuki, Yozo Miyake, Takeshi Iwata, Kazushige Tsunoda; Japan Eye Genetics Consortium: National Cohort Survey and Whole Exome Sequencing Results of Cone-rod dystrophy. Invest. Ophthalmol. Vis. Sci. 2020;61(7):2382.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We describe the clinical and genetic characteristics of a nationwide cohort with cone-rod dystrophy (CORD) in the Japanese population.

Methods : A cohort of 205 affected and 96 unaffected subjects from 183 Japanese families diagnosed with CORD (i.e. progressive retinal dystrophy initially often affecting the macula with generalized cone dysfunction greater than rod dysfunction) or Stargardt disease was ascertained between 2008 and 2018. Families with occult macular dystrophy or achromatopsia were not included. The clinical diagnosis was performed with comprehensive ophthalmic examinations at 38 institutes throughout the nation. Whole exome sequencing with target analysis on 301 retinal diseases-associated genes, and in silico molecular genetic analysis was performed in 311 subjects from 183 families.

Results : There were 83 female and 122 male patients. The median age of onset of the probands was 31.0 years (range, 0-75), and the median age at the latest examination was 44.5 years (range, 7-84). The median visual acuity in the LogMAR unit was 0.52 (range, -0.08-2.00) in the right eye and 0.52 (-0.08-2.00) in the left eye. Disease-causing/associated variants were determined in 85/183 (46.4%) families, including 39 (39/85, 45.9%) families with previously reported variants and 46 families (46/85, 54.1%) families with novel variants. In total, 104 disease-causing/associated in the 17 genes were identified; ABCA4, CRX, GUCY2D, EYS, POC1B, PROM1, PRPH2, RPGR, KCNV2, PDE6C, and others.

Conclusions : Conclusive molecular genetic diagnosis was obtained in around half of this Japanese CORD cohort. Novel disease-causing/associated variants are frequently revealed, which suggests the distinctive genetic background of the Japanese population. This national survey provides epidemiologic evidence of Japanese CORD, which promotes patients’ care and therapeutic trials in the Japanese population.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×